HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wolfgang Högler Selected Research

Rickets (Rachitis)

1/2022Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia.
1/2022Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.
1/2021Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia.
10/2020Nutritional rickets & osteomalacia: A practical approach to management.
4/2020New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management.
1/2020Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia.
1/2019Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
1/2019Spot the silent sufferers: A call for clinical diagnostic criteria for solar and nutritional osteomalacia.
1/2018Burosumab Therapy in Children with X-Linked Hypophosphatemia.
1/2018Cardiac, bone and growth plate manifestations in hypocalcemic infants: revealing the hidden body of the vitamin D deficiency iceberg.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wolfgang Högler Research Topics

Disease

19Rickets (Rachitis)
01/2022 - 06/2007
8Vitamin D Deficiency
10/2020 - 03/2010
8Osteomalacia
10/2020 - 06/2015
7Osteogenesis Imperfecta (Lobstein Disease)
12/2021 - 10/2009
7Pain (Aches)
01/2021 - 01/2007
6Osteoporosis
07/2022 - 03/2010
6Hypophosphatasia
11/2020 - 06/2007
5Congenital Abnormalities (Deformity)
01/2022 - 01/2015
4Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia)
01/2022 - 01/2018
4Metabolic Bone Diseases (Osteopenia)
10/2019 - 02/2007
4Seizures (Absence Seizure)
01/2017 - 02/2007
3Hypophosphatemia
01/2022 - 01/2018
2Chronic Disease (Chronic Diseases)
07/2022 - 04/2014
2Phenylketonurias (Phenylketonuria)
06/2021 - 04/2021
2Pseudohypoaldosteronism
05/2021 - 05/2013
2Hypocalcemia
01/2021 - 01/2018
2Nephrocalcinosis
01/2021 - 06/2007
2Hypoparathyroidism
01/2021 - 01/2018
2Disease Progression
02/2019 - 02/2007
2Hypercalcemia (Milk Alkali Syndrome)
01/2018 - 06/2007
2Body Weight (Weight, Body)
01/2018 - 03/2010
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2017 - 06/2015
2Liver Diseases (Liver Disease)
03/2012 - 03/2010
2Bone Resorption
03/2010 - 05/2003
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2022
1Abscess
01/2022
1Musculoskeletal Diseases (Musculoskeletal Disease)
01/2022
1Rare Diseases (Rare Disease)
01/2021
1Postmenopausal Osteoporosis
01/2021
1Diarrhea
01/2021
1type 1 familial Hypocalciuric hypercalcemia
01/2021
1Fatigue
01/2021
1Hyperphosphatemia
01/2021
1Hyperparathyroidism
01/2021
1Hypopituitarism (Sheehan's Syndrome)
01/2021
1Autoimmune Polyendocrinopathies (Schmidt Syndrome)
01/2021
1Metabolic Diseases (Metabolic Disease)
11/2020
1Hematologic Diseases (Blood Diseases)
01/2020
1Leukemia
01/2020
1Osteosarcoma (Osteogenic Sarcoma)
10/2019
1Adrenocortical Carcinoma
03/2019
1Failure to Thrive
02/2019
1Acute Kidney Injury (Acute Renal Failure)
01/2018
1Heart Arrest (Cardiac Arrest)
01/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Osteonecrosis (Kienbock's Disease)
01/2018

Drug/Important Bio-Agent (IBA)

15CalciumIBA
01/2021 - 11/2013
11Vitamin DFDA LinkGeneric
01/2022 - 11/2013
10Alkaline PhosphataseIBA
01/2022 - 05/2003
7Phosphates (Orthophosphate)IBA
01/2022 - 09/2015
7Parathyroid Hormone (Parathormone)IBA
01/2021 - 03/2010
5burosumabIBA
01/2022 - 01/2018
5N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA
11/2020 - 06/2007
4Fibroblast Growth Factor-23IBA
01/2022 - 01/2018
4Phosphorus (Red Phosphorus)IBA
01/2021 - 09/2015
4Dietary CalciumIBA
10/2020 - 01/2016
4Diphosphonates (Bisphosphonates)IBA
01/2018 - 12/2015
3SteroidsIBA
07/2022 - 10/2013
3SaltsIBA
01/2022 - 02/2012
3Monoclonal AntibodiesIBA
01/2022 - 01/2018
3Proteins (Proteins, Gene)FDA Link
04/2021 - 10/2009
3Pharmaceutical PreparationsIBA
01/2021 - 02/2007
3MicronutrientsIBA
01/2020 - 01/2016
3EnzymesIBA
01/2019 - 03/2010
2Calcitriol (Calcijex)FDA LinkGeneric
01/2022 - 09/2015
2Hormones (Hormone)IBA
01/2021 - 01/2021
2asfotase alfaIBA
11/2020 - 01/2019
2IronIBA
01/2020 - 09/2015
2MineralsIBA
01/2019 - 09/2007
2Zoledronic Acid (Zometa)FDA Link
01/2018 - 09/2007
2Pamidronate (Aredia)FDA LinkGeneric
01/2018 - 01/2016
2Collagen Type I (Type I Collagen)IBA
12/2016 - 01/2016
225-hydroxyvitamin DIBA
11/2013 - 03/2010
2Cholecalciferol (Vitamin D3)FDA Link
03/2012 - 03/2010
2Ergocalciferols (Ergocalciferol)FDA LinkGeneric
03/2012 - 03/2010
1alpha2 Subunit Collagen Type IIBA
12/2021
1RNA Splice SitesIBA
12/2021
1N-benzyl-N-methyl-dodecan-1-amineIBA
06/2021
1Epithelial Sodium ChannelsIBA
05/2021
1caseinomacropeptideIBA
04/2021
1NitrogenIBA
04/2021
1Amino AcidsFDA Link
04/2021
1Calcium-Sensing ReceptorsIBA
01/2021
1ametantrone (HAQ)IBA
11/2020
1EndopeptidasesIBA
04/2020
1Complementary DNA (cDNA)IBA
10/2019
1Androstenedione (4 Androstene 3,17 dione)IBA
03/2019
1PHEX Phosphate Regulating Neutral EndopeptidaseIBA
01/2019
1benzoyl L-arginine methyl ester (BAME)IBA
01/2018
1DenosumabFDA Link
01/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2018
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2018
1LigandsIBA
01/2018

Therapy/Procedure

15Therapeutics
01/2022 - 01/2007
2Aftercare (After-Treatment)
01/2018 - 01/2007
2Liver Transplantation
03/2012 - 03/2010
1Diet Therapy (Therapy, Diet)
06/2021
1Hematopoietic Stem Cell Transplantation
01/2020
1Orthopedic Procedures
02/2019
1Drug Therapy (Chemotherapy)
01/2018